Inherited bone marrow failure syndromes (IBMFS) are genetic disorders of impaired hematopoiesis that manifest in childhood with both cytopenias and extrahematologic findings. Although several IBMFS are categorized as ribosomopathies owing to shared underlying ribosomal dysfunction, there is a broader disruption of the protein homeostasis (proteostasis) network across both classic and emerging IBMFS. Precise regulation of the proteostasis network, including mechanisms of protein synthesis, folding, trafficking, and degradation and associated stress response pathways, has emerged as essential for maintaining hematopoietic stem cell function, providing new potential mechanistic insights into IBMFS pathogenesis. Furthermore, the varied clinical trajectories of patients with IBMFS with possible divergent outcomes of malignancy and spontaneous remission may reflect developmental and temporal changes in proteostasis activity and be driven by strong selective pressures to restore proteostasis. These new insights are spurring fresh therapeutic approaches to target proteostasis. Thus, further evaluation of proteostasis regulation and the consequences of proteostasis disruption in IBMFS could aid in developing new biomarkers, therapeutic agents, and preventive approaches for patients.
Skip Nav Destination
PERSPECTIVE|
July 17, 2025
Proteostasis disruption in inherited bone marrow failure syndromes Available to Purchase
Helena Yu,
Helena Yu
1Department of Pediatric Hematology/Oncology, Rady Children’s Hospital–San Diego, San Diego, CA
2Division of Hematology/Oncology, Department of Pediatrics, University of California San Diego, La Jolla, CA
3Division of Regenerative Medicine, Department of Medicine, Sanford Stem Cell Institute Discovery Center, Moores Cancer Center, University of California San Diego, La Jolla, CA
Search for other works by this author on:
Robert A. J. Signer
Robert A. J. Signer
3Division of Regenerative Medicine, Department of Medicine, Sanford Stem Cell Institute Discovery Center, Moores Cancer Center, University of California San Diego, La Jolla, CA
Search for other works by this author on:
Blood (2025) 146 (3): 304–317.
Article history
Submitted:
December 11, 2024
Accepted:
February 24, 2025
First Edition:
March 16, 2025
Citation
Helena Yu, Robert A. J. Signer; Proteostasis disruption in inherited bone marrow failure syndromes. Blood 2025; 146 (3): 304–317. doi: https://doi.org/10.1182/blood.2024024956
Download citation file:
My Account
Sign In
July 17 2025
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal